Chemotherapy‐induced peripheral neuropathy (CIPN) is a common dose‐limiting side effect
experienced by patients receiving treatment for cancer. Approximately 30 to 40% of patients …

Next-generation sequencing (NGS) technology has expanded in the last decades with
significant improvements in the reliability, sequencing chemistry, pipeline analyses, data …

Abstract The Dutch Pharmacogenetics Working Group (DPWG) aims to facilitate
pharmacogenetics implementation in clinical practice by developing evidence-based …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common toxicity associated with
chemotherapy, but researchers rarely study its risk factors, fall risk, and prevalence in long …

Abstract Paclitaxel (Brand name Taxol) is widely used in the treatment of common cancers
like breast, ovarian and lung cancer. Although highly effective in blocking tumor progression …

Paclitaxel is an anticancer agent efficacious in the treatment of ovarian, breast, and lung
cancer. Due to a strong link between the pharmacokinetics and therapeutic efficacy of …

Introduction Chemotherapy‐induced neuropathies are one of the most common side effects
of cancer treatment, surpassing bone marrow suppression and kidney dysfunction …

Purpose: Taxane-induced peripheral neuropathy (TIPN) is an important survivorship issue
for many cancer patients. Currently, there are no clinically implemented biomarkers to …

Individuals differ substantially in their response to pharmacological treatment. Personalized
medicine aspires to embrace these inter-individual differences and customize therapy by …

Taxane-derived agents are chemotherapy drugs widely employed in cancer treatment.
Among them, paclitaxel and docetaxel are most commonly administered, but newer …